x
Ariana Pharma
[contact-form-7 404 "Not Found"]

Ariana Pharma
  • Contact Us
  • Home
  • About Us
  • Our Business
  • Our Technology
  • Real World Data
  • News & more
    • In The News
    • Case study
    • Publications
      • Publications & Conferences
      • Whitepaper & blog
  • Careers
Logo

Contact Info

  • 58-60 Avenue de la Grande Armée, 75017, Paris, France
  • +33 1 44 37 17 00
  • info@arianapharma.com

Alzheimer’s Association International Conference (AAIC) 2018, Chicago, USA

Hampel, H. et al. Full Genomic Analysis of Anavex®2-73 Phase 2a Alzheimer’s Disease Study Identifies Biomarkers Enabling Targeted Therapy and a Precision Medicine Approach. in Alzheimer’s Association International Conference (AAIC) 2018 vol. 14 P1519–P1520 (2018).

Publication

Hampel, H. et al. Systematic Processing of Full Genomic Analysis of the Anavex®2-73 Phase 2a Alzheimer’s Disease Study Identifies Biomarkers Enabling a Precision Medicine Approach. in Alzheimer’s Association International Conference (AAIC) 2018 vol. 14 P1666–P1667 (John Wiley & Sons, Ltd, 2018).

Publication

Ariana Pharmaceuticals, The AI DRUG Development Company

  • Paris, FRANCE / Cambridge, MA, USA
  • Call Us: +33 144 37 17 00
  • info@arianapharma.com

Menu

  • About Us
  • Our business
  • Technology
  • In The News
  • Contact Us

Subscribe

Keep in touch and subscribe to our latest news

    Ariana Pharma © 2024 All Rights Reserved